| Pharmaceutical Information |
| Drug Name |
Mivacurium chloride |
| Drug ID |
BADD_D01482 |
| Description |
Mivacurium is a bisbenzylisoquinolinium based neuromuscular blocker or muscle relaxant. It binds competitively to cholinergic receptors on the motor end-plate to antagonize the action of acetylcholine, resulting in a block of neuromuscular transmission. |
| Indications and Usage |
For inpatients and outpatients, as an adjunct to general anesthesia, to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. |
| Marketing Status |
approved |
| ATC Code |
M03AC10 |
| DrugBank ID |
DB01226
|
| KEGG ID |
D00763
|
| MeSH ID |
D000077590
|
| PubChem ID |
5281080
|
| TTD Drug ID |
D0OB2M
|
| NDC Product Code |
46439-8764 |
| UNII |
600ZG213C3
|
| Synonyms |
Mivacurium | Mivacurium Chloride | BW B1090U | BW-B-1090U | BWB1090U | BW-B1090U | BW-B 1090U | BW B 1090U | BWB 1090U | Mivacron |
|
| Chemical Information |
| Molecular Formula |
C58H80Cl2N2O14 |
| CAS Registry Number |
106861-44-3 |
| SMILES |
C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC
[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C.[Cl-].[Cl-] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
